United States News All stories

ACCO Brands reported its fourth-quarter and full-year 2025 results on Monday, highlighting a resilient bottom line and expansion in gaming accessories despite a broader slowdown in global demand for traditional office products.

Bristol Myers Squibb reached a major milestone in its next-generation protein degradation program on Monday, reporting that its oral CELMoD agent, mezigdomide, significantly extended the time patients lived without their cancer progressing in a pivotal Phase 3 study.

Pfizer announced positive topline results for its investigational trispecific antibody, tilrekimig, which demonstrated significant skin clearance in adults with moderate to severe eczema and paved the way for a pivotal Phase 3 study later this year.

Korn Ferry (NYSE:KFY) reported a strong third quarter for fiscal 2026, with fee revenue reaching $717.4 million as the global consulting firm successfully leveraged high-growth digital services and long-term contracts to offset broader economic shifts.

ARS Pharmaceuticals reported its 2025 financial results on Monday, highlighting the successful U.S. commercial launch of neffy, the first needle-free epinephrine nasal spray, which now anchors the company’s path toward cash-flow break-even.

Heritage Insurance Holdings (NYSE:HRTG) capped a landmark fiscal year with a surge in fourth-quarter net income, as a dramatically improved combined ratio and strategic geographic expansion propelled book value to record heights.

Signet Jewelers (NYSE:SIG) reported preliminary full-year 2026 results on Monday, revealing that a shift toward higher-end merchandise successfully bolstered annual growth despite a slight cooling in fourth-quarter store traffic.

BETA Technologies reported a significant jump in full-year 2025 revenue following its market debut, as the electric aerospace pioneer scales its charging infrastructure and begins high-volume deliveries of its proprietary propulsion systems.

IDEAYA Biosciences reached a key clinical milestone on Monday, dosing the first patient in its Phase 1 trial for IDE892, a potential best-in-class PRMT5 inhibitor designed to target MTAP-deleted solid tumors.

Woodward signed a definitive agreement on Monday to acquire Florida-based Valve Research & Manufacturing Company, a move designed to deepen the industrial giant’s component density on both current and future-generation aircraft platforms.

HUTCHMED initiated a full market recall of the oncology drug Tazverik across Greater China on Monday, following a global withdrawal by partner Ipsen due to emerging safety data linking the therapy to secondary blood cancers.

AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo moved a step closer to a major label expansion for their blockbuster cancer therapy, Enhertu, after the U.S. FDA fast-tracked an application to treat patients with early-stage breast cancer at high risk of recurrence.

STMicroelectronics (NYSE:STM) has launched high-volume production of its PIC100 silicon photonics platform, positioning itself as a primary supplier for the 800G and 1.6T transceivers required to power the global AI infrastructure "super-cycle.

Agilent Technologies (NYSE:A) moved to significantly expand its clinical oncology presence on Monday, announcing an all-cash deal for Biocare Medical that adds a high-growth portfolio of cancer-staining antibodies and reagents.

Iran's Assembly of Experts has named Mojtaba Khamenei as the nation’s third Supreme Leader.

Adial Pharmaceuticals (NASDAQ:ADIL) reported a significant reduction in annual net losses for 2025, as the clinical-stage biotech firm secures FDA alignment and strategic partnerships to transition its lead alcohol-use disorder candidate into Phase 3 trials.

Global energy markets are reeling as oil tracks toward its most significant weekly gain in four years, fuelled by escalating conflict in the Middle East.

Diana Shipping escalated its pursuit of Genco Shipping & Trading on Friday, raising its all-cash offer to $23.50 per share in a sweetened bid backed by a $1.43 billion financing package and a strategic vessel-sale agreement with Star Bulk Carriers.

Imperial Petroleum reported a surge in fourth-quarter revenue and sustained annual profitability, as the Athens-based shipowner leverages a debt-free balance sheet to aggressively expand its presence in the tanker and drybulk markets.

Tsakos Energy Navigation (NYSE:TEN) posted a sharp rise in full-year profitability for 2025, as the Greek tanker major capitalized on high fleet utilization and a strategic push into the LNG and specialized vessel markets.

SunCar Technology Group (NASDAQ:SDA) issued a bullish outlook for the coming fiscal year, forecasting a 20% jump in revenue as the digital auto platform leverages artificial intelligence and deepening electric vehicle (EV) partnerships to drive profitability.

Halozyme Therapeutics (NASDAQ:HALO) shares were in focus Friday after partner Johnson & Johnson secured U.S. regulatory approval for a subcutaneous combination therapy that significantly reduces the risk of disease progression in patients with relapsed multiple myeloma.

Hurco Companies (NASDAQ:HURC) reported a reduced net loss for the first quarter of fiscal 2026, finding a silver lining in a double-digit surge in domestic orders despite a dip in global sales.

PMV Pharmaceuticals (NASDAQ:PMVP) reported significant clinical momentum for its lead candidate, rezatapopt, bolstered by a fresh FDA Orphan Drug Designation and clinical results showing high response rates in late-stage ovarian cancer patients.